ePoster

ELEVATED VOLTAGE-GATED SODIUM CHANNEL CURRENTS AND ALTERED SYNAPTIC CONNECTIVITY IN AN IN VITRO MODEL OF BIPOLAR DISORDER AND SCHIZOPHRENIA

Ana Gonzalez Ramosand 8 co-authors

Broad Institute of MIT and Harvard

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS01-07AM-511

Presentation

Date TBA

Board: PS01-07AM-511

Poster preview

ELEVATED VOLTAGE-GATED SODIUM CHANNEL CURRENTS AND ALTERED SYNAPTIC CONNECTIVITY IN AN IN VITRO MODEL OF BIPOLAR DISORDER AND SCHIZOPHRENIA poster preview

Event Information

Poster Board

PS01-07AM-511

Abstract

Common-variant genome-wide association studies for schizophrenia (SCZ) and bipolar disorder (BD) explain limited variance. Two recent exome meta-analyses, SCHEMA and BipEx, revealed ultra-rare loss-of-function (LoF) mutations in genes with odds ratios 5-50, providing high-penetrance entry points for mechanistic study of psychiatric illness. Among these, AKAP11 emerges as shared large-effect risk gene. We hypothesize that AKAP11 loss, a central regulator of PKA, alters neuronal excitability and synaptic development. Using CRISPR/Cas9, we generated heterozygous and homozygous AKAP11 LoF mutations in human embryonic stem cells; parallel CRISPR-interference knock-downs were created in induced pluripotent stem cells. Lines were differentiated into excitatory cortical-like neurons (hNs) by NGN2 overexpression. Whole-cell patch-clamp revealed increased voltage-gated sodium currents (VGNaC) and quantal synaptic properties. Proteomic analysis suggests this VGNaC increase is driven by elevated channel protein levels. Preliminary high-content imaging indicates increased somatodendritic complexity alongside synaptic density deficits. We are currently performing high-throughput physiological measurements, pharmacological experiments, and calcium imaging to explore broader network connectivity. Modeling high-penetrance LoF mutations in hNs has revealed sizeable, directionally consistent alterations in VGNaC and somatodendritic architecture. These phenotypes align with post-mortem reports of reduced synaptic density and perturbed VGNaC expression in patient's cortex. Our isogenic hNs platform effectively bridges genetic findings to cellular pathophysiology, providing a quantitative assay suitable for mechanistic dissection and therapeutic screening.

Recommended posters

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.